Mpox vaccine immune response under the microscope in DRC
NCT ID NCT07499739
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 300 adults in the Democratic Republic of the Congo who received either the MVA-BN or LC16m8 mpox vaccine as part of a national campaign. Researchers collect blood samples at several time points to measure how well the vaccines trigger and maintain antibodies against the mpox virus. The goal is to understand the strength and duration of the immune response, which can help improve future vaccination efforts.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MVA-BN or LC16m8 mpox vaccine
What this could lead to
If successful, this study will clarify how well these vaccines trigger and maintain immunity against mpox, guiding future vaccination strategies.
What could go wrong
This is an observational study, not a treatment trial. Results may not apply to other populations, and immune response does not guarantee protection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MPOX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Convivial Kasa-Vubu
Kinshasa, Democratic Republic of the Congo
-
Kinoise
Kinshasa, Democratic Republic of the Congo
-
Kokolo
Kinshasa, Democratic Republic of the Congo